52 filings
8-K
PBTH
PROLOR Biotech, Inc.
30 Aug 13
Completion of Acquisition or Disposition of Assets
12:00am
8-K
PBTH
PROLOR Biotech, Inc.
3 Jul 13
PROLOR BIOTECH TO PRESENT POSITIVE RESULTS FROM PRECLINICAL STUDIESOf
12:00am
8-K
PBTH
PROLOR Biotech, Inc.
17 Jun 13
Regulation FD Disclosure
12:00am
8-K
PBTH
PROLOR Biotech, Inc.
7 Jun 13
Departure of Directors or Certain Officers
12:00am
8-K
PBTH
PROLOR Biotech, Inc.
4 Jun 13
PROLOR BIOTECH initiates PIVOTAL phase III trial of ITS Longer-Acting Version of human growth hormone
12:00am
8-K
hks6vpwtvy sdshw
29 Apr 13
Entry into a Material Definitive Agreement
12:00am
8-K
0a67wkf0glp 9jchhcrg
24 Apr 13
Opko Health to Acquire Prolor Biotech
12:00am
8-K
mhaskdb s21l8zhiw
8 Feb 13
Departure of Directors or Certain Officers
12:00am
8-K
6bj42
6 Feb 13
PROLOR BIOTECH TO PRESENT NEW PRECLINICAL DATA ON ITS LONG-ACTING CLOTTING FACTOR Vlla AT LEADING EUROPEAN SCIENTIFIC CONFERENCE
12:00am
8-K
l274nmcg qxmz24
12 Dec 12
Regulation FD Disclosure
12:00am
8-K
29kipc kz
7 Dec 12
PROLOR BIOTECH TO PRESENT PRECLINICAL DATA ON ITS LONG-ACTING CLOTTING FACTOR Vlla AT 2012 ASH ANNUAL MEETING
12:00am
8-K
jnpt0tc82
7 Nov 12
Departure of Directors or Certain Officers
12:00am
8-K
2642qe
7 Jun 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
rep8hn fn8wmxi5
14 May 12
PROLOR BIOTECHAnnounces PROPOSED Public Offering of Common Stock
12:00am
8-K
ep9w3kk
10 May 12
Entry into a Material Definitive Agreement
12:00am
8-K
j7m8y8aody 40
7 May 12
Regulation FD Disclosure
12:00am
8-K
9r5lxc vxwnth45f
20 Apr 12
PROLOR Biotech Receives Letter from NYSE Amex Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders
12:00am
8-K
xhm0q uxz1gi7
19 Apr 12
Long Acting Reversible PEGylated Oxyntomodulin - MOD - 6030 Apr 2012 5th Diabetes Drug Discovery & Development Conference
12:00am
8-K
mlrqfawc2ck u94
24 Feb 12
Regulation FD Disclosure
12:00am
8-K
f00rl03k6 qt3hxlb6d
9 Jun 11
Submission of Matters to a Vote of Security Holders
12:00am